If any controlled substance appears in the listed bulk database, please ignore it, as we do not supply or offer controlled substances.
Cinitapride Impurity 8
100% accuracy
of data
24/7 scientific
support
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

86718-17-4Cinitapride Impurity 8

● In Stock

Catalogue No.:VE0028336
CAS No.:86718-17-4
Mol. Formula:C10H12N2O5
Mol. Weight:240.21 g/mol

Additional information on CAS 86718-17-4

Parent drug

Cinitapride

IUPAC Name

methyl 4-amino-2-ethoxy-5-nitrobenzoate

Pharmacopeial Synonyms

N/A

Synonyms

N/A

Smiles

O=C(OC)C1=C(OCC)C=C(N)C([N+]([O-])=O)=C1

InChI

InChI=1S/C10H12N2O5/c1-3-17-9-5-7(11)8(12(14)15)4-6(9)10(13)16-2/h4-5H,3,11H2,1-2H3

Description

Cinitapride Impurity 8 (CAS 86718-17-4) is a pharmaceutical process-related degradant observed during synthesis and storage of cinitapride drug substance. Typically detected at trace levels by HPLC and characterized by LC-MS and 1H/13C NMR, its analytical characterization is essential for accurate identification and quantification. The impurity profile suggests formation via incomplete substitution or hydrolytic pathways, driving targeted control strategies such as optimized reaction conditions, enhanced purification and validated stability studies. Defined specification limits, routine monitoring and robust isolation methods support regulatory compliance and consistent impurity clearance across manufacturing batches.

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
This field is hidden when viewing the form
Products quotation
Name
Url
 
This field is hidden when viewing the form
This field is hidden when viewing the form